The class II anthracycline antitumor antibiotics musettamycin, rudolfomycin, aclacinomycin and marcellomycin, which were shown in earlier studies to preferentially inhibit the synthesis of nucleolar RNA in intact tumor cells, were studied in an isolated nucleolar transcriptional assay. Their effects were compared with those of the nucleolar non-selective anthracyclines adriamycin, carminomycin and pyrromycin, as well as with the 10-descarbomethoxyanalogs of marcellomycin and rudolfomycin.
A biochemical method employing a cell-free homogenate to screen for antitumor antibiotics was previously reported by NITTA and co-workers1) and was used successfully to detect phenomycin, an inhibitor of protein synthesis2>. Recently, SAKANO and co-workers3) employed a purified mouse RNA polymerase assay to detect nucleic acid active antitumor agents. However, no studies on the use of isolated nuclei or nucleoli as a screen for antitumor agents with specific mechanisms of action have been reported.
Anthracyclines represent a major class of antitumor antibiotics and include the analogs adriamycin4,5) (ADM), carminomycin4,5.6) (CMM), aclacinomycin4,5,7,8) (ACM) and marcellomycin5.9) (MCM).
The results of extensive studies by many groups have demonstrated that these compounds can exert a variety of biochemical effects on cells, including DNA template interactions and the resultant perturbation of normal nucleic acid synthesis and metabolism4, 5, 6, 7, 8, 9) ,This latter effect is thought to play a significant role in the antitumor action of the anthracyclines.
We have previously demonstrated that anthracyclines can be divided into two classes based upon their selectivity for the inhibition of nucleolar pre-ribosomal RNA (No-RNA) synthesis in intact mammalian tumor cells grown in cultures5,9). This assay compared the results of two separate determinations to evaluate the nucleolar selectivity of a drug by taking the ratio of the IC50 value for DNA synthesis to the IC50 value for No-RNA synthesis5,9). In addition to detecting the nucleolar-specific actions of drugs, the assay was both sensitive and reproducible. However, the methods employed in these studies do not allow rapid screening of compounds because the procedures used are time and compound consuming, Thus, the assay proved impractical for screening large numbers of compounds, and consequently many potentially nucleolar selective agents may go undetected. Therefore, the present study was undertaken to determine whether effects on isolated nucleoli could be employed to predict for selectivity of No-RNA synthesis inhibition in vivo among the anthracyclines.
Nucleoli were isolated from NOVIKOFF hepatoma ascites cells as previously described by BALLAL and co-workers10). RNA synthesis in isolated nucleoli was assayed according to previously reported methods10,11,12). Table I lists the IC,, values for No-RNA synthesis in isolated nucleoli of the 9 anthracyclines studied. In addition, the effect of actinomycin D was examined, and an IC50 value of 0.98 /OM was obtained. Based on the relative potencies for the inhibition of transcriptional activities in vitro, the current results are in good correlation with the previous studies using intact cells5,9), even though absolute IC50 values differed between the two assay systems.
To test the validity of the in vitro assay, the relative nucleolar selectivities of the drugs were compared for the two assays. In the present study, using the IC,, values for DNA synthesis previously determined for each of the nine anthracyclines studied5,9) and the IC., values for No-RNA synthesis in isolated nucleoli (Table 1) , the nucleolar selectivities of the anthracyclines were determined as indicated in Table 2 .
Although the absolute values of the ratios differ significantly from those previously determined in whole cells for each anthracycline5.9), the three groups of anthracyclines can readily be distinguished and are equivalent by both methods. Class I anthracyclines, ADM, CMM and PYM, had the lowest ratios and the class II anthracyclines, MSM, MCM, ACM and RDM, had significantly higher values, while the descarbomethoxy-analogs of RDM and MCM had intermediate ratios. Thus, the utility of the isolated nucleoli system screening assay to detect nucleolar selective anthracyclines is demonstrated. The IC,, values for No-RNA synthesis obtained in this study vary from 9-fold to greater than 25-fold higher than values noted when intact cells were studied5,9). The decreased No-RNA synthesis inhibitory potency of anthracyclines studied in isolated nucleoli may be accounted for on the basis of a reduction of (or absence of) reinitiation of preribosomal RNA chains in isolated nucleoli10,16). Al- 
Isolation of Nucleoli
Nucleoli were isolated from 6-day old NOVIKOFF hepatoma ascites cells by the methods of BALLAL and co-workers10). Nucleoli were suspended in 0.05 M Tris-HCl, pH 7.9, 50% glycerol, 1 MM MgC12, 0.05 mM phenylmethyl sulfonyl fluoride (PMSF), 2 mm dithiothreitol, 0.1 mm EDTA, and stored at -80°C .
RNA Synthesis in Isolated Nucleoli
Transcriptional activity was assayed according to previously reported methods10,11,12) The assay buffer contained: 50 mm Tris-HCl, pH 7.9, 0.1 M KCl, 2 mm dithiothreitol, 0.05 mm PMSF, 5 mm KF, 5 mm MgCl2, 1 mm ATP, 1 mm GTP, 1 mm CTP, 0.2 mm UTP, 5.0 pCi/ml 3H-UTP, plus varying concentrations of anthracyclines. The final assay volume was 0.10m], and reactions were initiated by the addition of 0.01 -0.02 ml of nucleoli (approximately 55 N•g DNA). Reactions were run at 30°C for 30 minutes and 0.05 ml aliquots were processed as previously reported12). Results were displayed as percent inhibition versus log of drug concentration, and subjected to probit analysis as previously described5,9,15). Best fit lines were constructed and the IC50 values estimated as previously reported5,9).
